Tomoko Tanaka
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Combined MEK and YAP inhibition in a mouse model of neuroblastoma: A promising approach for minimal residual disease.
Journal: Journal of pediatric surgery
Published: March 06, 2025
The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma.
Journal: Biochemical and biophysical research communications
Published: May 27, 2021
Anti-relapse effect of trametinib on a local minimal residual disease neuroblastoma mouse model.
Journal: Journal of pediatric surgery
Published: March 04, 2021
Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma.
Journal: Pediatric surgery international
Published: November 06, 2020
Novel mesenchymal stem cell delivery system as targeted therapy against neuroblastoma using the TH-MYCN mouse model.
Journal: Journal of pediatric surgery
Published: August 15, 2019
In vivo effects of short- and long-term MAPK pathway inhibition against neuroblastoma.
Journal: Journal of pediatric surgery
Published: August 02, 2018
Mesenchymal hamartoma of the chest wall in a 10-year-old girl mimicking malignancy: a case report.
Journal: Skeletal radiology
Published: March 23, 2018
Disruption of circadian clockwork in in vivo reprogramming-induced mouse kidney tumors.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: November 17, 2017
Tumor-homing effect of human mesenchymal stem cells in a TH-MYCN mouse model of neuroblastoma.
Journal: Journal of pediatric surgery
Published: August 18, 2016
MEK inhibitors as a novel therapy for neuroblastoma: Their in vitro effects and predicting their efficacy.
Journal: Journal of pediatric surgery
Published: August 18, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026